Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.92ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.92ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.92NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.145ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.145ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.145ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.145NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.120ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.120ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.120ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.120NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.77ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.77ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.77ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.77NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AE.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AE.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AE.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AE.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.504ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.504ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
B.1.504ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20103.9China
B.1.504NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AE.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AE.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AE.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AE.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.201ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.201ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.201ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.201NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.221ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.221ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.221ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.221NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.410ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.410ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.410ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.410NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.411ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.411ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.411ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.411NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.513ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.513ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.513ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.513NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.338ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.338ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.338ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used